ES8200558A1 - Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal. - Google Patents

Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.

Info

Publication number
ES8200558A1
ES8200558A1 ES491621A ES491621A ES8200558A1 ES 8200558 A1 ES8200558 A1 ES 8200558A1 ES 491621 A ES491621 A ES 491621A ES 491621 A ES491621 A ES 491621A ES 8200558 A1 ES8200558 A1 ES 8200558A1
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
procedure
producing
application via
via transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES491621A
Other languages
English (en)
Other versions
ES491621A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C.H. Boehringer Sohn AG and Co KG
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6071291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8200558(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by C.H. Boehringer Sohn AG and Co KG filed Critical C.H. Boehringer Sohn AG and Co KG
Publication of ES491621A0 publication Critical patent/ES491621A0/es
Publication of ES8200558A1 publication Critical patent/ES8200558A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00—Surgery: splint, brace, or bandage
    • Y10S602/90—Method of making bandage structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

CONSISTE EN VERTER UNA DISPERSION DE POLIACRILATO SOBRE UNS SUPERFICIE PLANA (EVENTUALMENTE DESPUES DE ADICION PREVIA D E SUSTANCIAS AUXILIARES HIDROFILAS Y/O MEDICAMENTOS BIEN SOLUBLES EN AGUA); A CONTINUACION LOS MEDICAMENTOS EN FORMA DE UNA SOLUCION EN DISOLVENTES ORGANICOS SOBRE LA PELICULA SECA, DESPUES DE LO CULA SE EVAPORA EL DISOLVENTE. EN CASO NECESARIO SE PUEDE APLICAR DE NUEVO LA DISPERSION SOBRE LA PELICULA UNA O VARIAS VECES. COMO MATERIAL DE PARTIDA PARA LA PREAPARCION DE LA PELICULA SE EMPLEA UN DISPERSION ACUOSA DE POLIACRILATO.
ES491621A 1979-05-21 1980-05-20 Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal. Expired ES8200558A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792920500 DE2920500A1 (de) 1979-05-21 1979-05-21 Pharmazeutische zubereitung in form eines polyacrylatfilmes

Publications (2)

Publication Number Publication Date
ES491621A0 ES491621A0 (es) 1981-11-01
ES8200558A1 true ES8200558A1 (es) 1981-11-01

Family

ID=6071291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES491621A Expired ES8200558A1 (es) 1979-05-21 1980-05-20 Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.

Country Status (17)

Country Link
US (1) US4409206A (es)
EP (1) EP0020905B1 (es)
JP (1) JPS5636413A (es)
AT (1) ATE8459T1 (es)
AU (1) AU537874B2 (es)
CA (1) CA1136045A (es)
DD (1) DD150849A5 (es)
DE (2) DE2920500A1 (es)
DK (1) DK154538C (es)
ES (1) ES8200558A1 (es)
FI (1) FI73884C (es)
IL (1) IL60114A (es)
MX (1) MX5879E (es)
NO (1) NO153637C (es)
PL (1) PL125847B1 (es)
YU (1) YU135980A (es)
ZA (1) ZA803009B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS57150503U (es) * 1981-03-17 1982-09-21
JPS5838213A (ja) * 1981-08-31 1983-03-05 Nitto Electric Ind Co Ltd 医薬製剤
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
US4608249A (en) * 1982-11-02 1986-08-26 Nitto Electric Industrial Co., Ltd. Hydrophilic therapeutic material
JPS6045522B2 (ja) * 1982-12-08 1985-10-09 憲司 中村 化粧用具
GR79183B (es) * 1983-04-27 1984-10-02 Lohmann Gmbh & Co Kg
AU3394884A (en) * 1983-08-31 1985-03-29 S.K.Y. Polymers Inc. Injectable physiologically acceptable polymeric compositions
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
DE3344618C2 (de) * 1983-12-09 1985-12-05 EGWA Apothekergenossenschaft eG, 7144 Asperg Verbandsstoff und Verfahren zu dessen Herstellung
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
EP0169364B1 (de) * 1984-06-23 1988-08-03 Beiersdorf Aktiengesellschaft Selbstklebendes Pflaster
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4685455A (en) * 1984-10-16 1987-08-11 Akzo Nv Watervapor-permeable, pressure sensitive, antiseptic wound covering material
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
CA1288698C (en) * 1985-08-30 1991-09-10 Rutgers, The State University Of New Jersey Transdermal anti-anginal pharmaceutical dosage
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
US4765974A (en) * 1985-12-24 1988-08-23 Nitto Electric Industrial Co., Ltd. Preparation for percutaneous administration
ATE71287T1 (de) * 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
CH672888A5 (es) * 1986-11-07 1990-01-15 Mepha Ag
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US4857313A (en) * 1987-05-28 1989-08-15 Warner-Lambert Company Transdermal drug delivery device comprising copolymers of N-morpholinoethyl methacrylate and 2-hydroxylmethacrylate
DE3728563A1 (de) * 1987-08-27 1989-03-09 Pohl Boskamp Gmbh Chem Pharma N-alkylscopolaminiumsalz und nitroglycerin enthaltendes arzneimittel, verfahren zu dessen herstellung und dessen verwendung
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
JPH07116035B2 (ja) * 1987-12-08 1995-12-13 塩野義製薬株式会社 被膜形成性抗真菌剤組成物
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
US6559186B1 (en) * 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
JPH0453907U (es) * 1990-09-14 1992-05-08
US5173302A (en) * 1990-09-28 1992-12-22 Medtronic, Inc. Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
DE4032096C2 (de) * 1990-10-10 1995-03-30 Boehringer Ingelheim Kg Verwendung emulgatorfreier Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe
ATE184473T1 (de) * 1992-06-11 1999-10-15 Theratech Inc Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
US5388588A (en) * 1993-05-04 1995-02-14 Nabai; Hossein Biopsy wound closure device and method
US5325857A (en) * 1993-07-09 1994-07-05 Hossein Nabai Skin biopsy device and method
US5394886A (en) * 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
DE4336299A1 (de) * 1993-10-25 1995-05-11 Arbo Robotron Medizin Technolo Gelkörper zur percutanen Verabreichung, insbesondere von Medikamenten
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
US5562653A (en) * 1994-11-16 1996-10-08 Hercules Incorporated Medical devices composed of low ceiling temperature polymers
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US6365178B1 (en) * 1996-09-06 2002-04-02 Watson Pharmaceuticals, Inc. Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
PT1019111E (pt) 1998-04-27 2002-10-31 Surmodics Inc Revestimento que liberta um agente bioactivo
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
DE10114247A1 (de) * 2001-03-22 2002-10-10 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Polymer-Kombination
US8496960B2 (en) * 2001-10-23 2013-07-30 Purdue Pharma L.P. Terazosin transdermal device and methods
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
WO2004000263A1 (en) 2002-06-25 2003-12-31 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
CN1964749A (zh) 2004-04-06 2007-05-16 苏莫迪克斯公司 用于生物活性剂的涂料组合物
ATE551995T1 (de) 2004-10-21 2012-04-15 Durect Corp Transdermale abgabesysteme
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US20080097380A1 (en) * 2006-09-21 2008-04-24 Li Kasey K Method and apparatus for creating variable stiffness and/or reduction of soft tissue
EP1920768A1 (en) 2006-11-10 2008-05-14 Abbott GmbH & Co. KG Solid dosage form with a film containing an active substance, as well as its method of production
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
BRPI0913214B1 (pt) * 2008-05-30 2022-05-17 Mylan Laboratories Inc Dispositivo de fornecimento de drogas transdérmico e método de fabricação do mesmo
CA2739380C (en) * 2008-10-06 2014-12-09 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
CA2911613A1 (en) 2013-03-29 2014-10-02 Centre National De La Recherche Scientifique (Cnrs) Cgrp receptor agonist for hiv treatment or prevention
CA2936806C (en) 2014-01-20 2022-03-15 Merial, Inc. Topical delivery formulation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1017747B (de) * 1953-06-10 1957-10-17 Bofors Ab Fluessiges Verbandmaterial
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
US3579628A (en) * 1967-07-03 1971-05-18 Johnson & Johnson Dressing film
NL6902314A (es) * 1969-02-13 1970-08-17
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
GB1394990A (en) * 1971-08-12 1975-05-21 Hydrophilics Int Inc Copolymers and compositions containing copolymers
DE2214306A1 (de) * 1972-03-24 1973-09-27 Dynamit Nobel Ag Wundfilm-spray
SE369276B (es) * 1972-12-27 1974-08-19 U Sweger
US4076798A (en) * 1975-05-29 1978-02-28 American Cyanamid Company High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition
US4013112A (en) * 1975-09-02 1977-03-22 International Harvester Company Anchor plate tire having a sub-lug equipped anchor plate
IT1085524B (it) * 1977-03-22 1985-05-28 Snam Progetti Materiali e fibre porose biocompatibili in grado di inglobare sostanze di interesse biologico e metodi per il loro ottenimento
DE2725261C2 (de) * 1977-06-03 1986-10-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally

Also Published As

Publication number Publication date
FI73884B (fi) 1987-08-31
CA1136045A (en) 1982-11-23
AU5858380A (en) 1980-11-27
DK154538C (da) 1989-04-17
NO153637C (no) 1986-05-21
PL224368A1 (es) 1981-07-10
EP0020905A1 (de) 1981-01-07
DE3068570D1 (en) 1984-08-23
JPS5636413A (en) 1981-04-09
FI801614A7 (fi) 1980-11-22
IL60114A (en) 1983-09-30
NO153637B (no) 1986-01-20
YU135980A (en) 1983-12-31
PL125847B1 (en) 1983-06-30
EP0020905B1 (de) 1984-07-18
JPH0220606B2 (es) 1990-05-10
IL60114A0 (en) 1980-07-31
DK154538B (da) 1988-11-28
AU537874B2 (en) 1984-07-19
ZA803009B (en) 1982-01-27
ES491621A0 (es) 1981-11-01
NO801490L (no) 1980-11-24
DE2920500A1 (de) 1980-11-27
ATE8459T1 (de) 1984-08-15
US4409206A (en) 1983-10-11
MX5879E (es) 1984-08-16
DD150849A5 (de) 1981-09-23
FI73884C (fi) 1987-12-10
DK175680A (da) 1980-11-22

Similar Documents

Publication Publication Date Title
AU537874B2 (en) Polyacrylate topical pharmaceutical
AU512328B2 (en) Skin patch for transdermal administration of clonidine
AU508480B2 (en) Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
NZ231001A (en) Dosage form or composition for administration of an abusable substance to the skin mucosa: permeable substance mixed with non-permeable antagonist
AU497383B2 (en) Method and bandage for administering scopolamine transdermally
PT814796E (pt) Uso de um farmaco r-aine numa composicao protectora para o tratamento do cancro colorectal
AU4129178A (en) Improvements in and relating to pharmaceutical preparations in solid unit dosage form
ES550011A0 (es) Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
SE7603325L (sv) Beredning med retard-effekt
ES482723A1 (es) Un procedimiento para la obtencion de una composicion de clotrimazol
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DK324687A (da) Transdermalt farmeceutisk praeparat
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
IE42950L (en) X-ray contrast preparations
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
DE2965732D1 (en) Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
CA1017675A (en) Use of l-prolyl l-leucyl glycine amide to treat parkinson's disease
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
BR8009059A (pt) Administracao de substancia medicas ativas
MY101916A (en) Etoposide oral dosage form.
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
AR219370A1 (es) Procedimiento de preparacion de composiciones farmaceuticas detoxificadas de agentes alquilantes citostaticamente activos